Resources
Proteomics Databases
Metabolomics Databases

-
Technical guide for De Novo Peptide Sequencing by Deep Learning: What It Changes in Spectrum Interpretation and Confidence Assessment.
-
• De Novo Sequencing Strategy: How to Choose Read Length, Platform Mix, and Assembly Path
Technical guide for De Novo Sequencing Strategy: How to Choose Read Length, Platform Mix, and Assembly Path.
-
Technical guide for De Novo Plasmid Sequencing: When Partial Read Confirmation Is Not Enough for Construct Verification.
-
Technical guide for Difference Between Re-Sequencing and De Novo Genome Assembly: How to Choose the Right Workflow for a New Genome Project.
-
Technical guide for De Novo Sequencing of Monoclonal Antibodies: Planning a Sequence Confirmation Strategy for Therapeutic mAbs.
-
Technical guide for How to Evaluate De Novo Peptide Sequencing Software Before Choosing In-House Analysis or External Interpretation Support.
-
Technical guide for De Novo Sequencing vs Database Search: Which Workflow Fits Novel Peptides, PTMs, and Low-Reference Discovery Projects?.
-
• De Novo Sequencing Methods in Proteomics: Where MS-Based Approaches Add the Most Value
Technical guide for De Novo Sequencing Methods in Proteomics: Where MS-Based Approaches Add the Most Value.
-
Technical guide for De Novo Sequencing vs Resequencing: Which Strategy Is Better for Novel Sequence Discovery Projects?.
-
• How to Optimize PhIP-Seq Immunoprecipitation Efficiency?
Introduction Low immunoprecipitation efficiency is one of the most common reasons a PhIP-Seq experiment produces weak, noisy, or difficult-to-interpret results. A serum sample may contain meaningful antibodies, but the final sequencing data can still show poor peptide enrichment when antibody binding, bead capture, washing, or library representation is not controlled. In autoimmune disease, infectious disease serology, vaccine response, or biomarker discovery, this can turn a promising sample set into......
How to order?
